San Diego, CA / February 20, 2008 – Novocell, Inc., a stem cell engineering company, announced data demonstrating for the first time that human embryonic stem (hES) cells can be turned into pancreatic cells capable of producing insulin in mice. The findings are reported in an article appearing on-line today, in advance of print publication, in the journal Nature Biotechnology. This research provides evidence supporting the potential future use of hES cells to replace insulin-producing pancreatic cells that are destroyed in people with Type 1 diabetes, requiring them to receive regular insulin treatment... Novocell's Press Release -
Tuesday, March 4, 2008
Novocell, Successful Use of Stem Cells to Generate Insulin in Mice
San Diego, CA / February 20, 2008 – Novocell, Inc., a stem cell engineering company, announced data demonstrating for the first time that human embryonic stem (hES) cells can be turned into pancreatic cells capable of producing insulin in mice. The findings are reported in an article appearing on-line today, in advance of print publication, in the journal Nature Biotechnology. This research provides evidence supporting the potential future use of hES cells to replace insulin-producing pancreatic cells that are destroyed in people with Type 1 diabetes, requiring them to receive regular insulin treatment... Novocell's Press Release -
